Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer

Ke Li(Hong Kong Polytechnic University), Yu Kang(Obstetrics and Gynecology Hospital of Fudan University)
Cancer Immunology Immunotherapy
September 27, 2022
Cited by 24


Related Papers